Baudax Bioinc Stock Probability of Future Stock Price Finishing Over 4.25

BXRX Stock  USD 0.01  0  18.75%   
Baudax BioInc's future price is the expected price of Baudax BioInc instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Baudax BioInc performance during a given time horizon utilizing its historical volatility. Check out Baudax BioInc Backtesting, Baudax BioInc Valuation, Baudax BioInc Correlation, Baudax BioInc Hype Analysis, Baudax BioInc Volatility, Baudax BioInc History as well as Baudax BioInc Performance.
For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.
  
Price Earnings Ratio is likely to drop to -0.02 in 2024. Price To Sales Ratio is likely to drop to 0.91 in 2024. Please specify Baudax BioInc's target price for which you would like Baudax BioInc odds to be computed.

Baudax BioInc Target Price Odds to finish over 4.25

The tendency of Baudax Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 4.25  or more in 90 days
 0.01 90 days 4.25 
close to zero percent
Based on a normal probability distribution, the odds of Baudax BioInc to move over $ 4.25  or more in 90 days from now is close to zero percent (This Baudax BioInc probability density function shows the probability of Baudax Stock to fall within a particular range of prices over 90 days) . Probability of Baudax BioInc price to stay between its current price of $ 0.01  and $ 4.25  at the end of the 90-day period is over 95.52 .
Given the investment horizon of 90 days Baudax BioInc has a beta of -0.54 suggesting as returns on benchmark increase, returns on holding Baudax BioInc are expected to decrease at a much lower rate. During the bear market, however, Baudax BioInc is likely to outperform the market. Moreover Baudax BioInc has an alpha of 1.0552, implying that it can generate a 1.06 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Baudax BioInc Price Density   
       Price  

Predictive Modules for Baudax BioInc

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Baudax BioInc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Baudax BioInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.019.65
Details
Intrinsic
Valuation
LowRealHigh
0.000.019.65
Details
Naive
Forecast
LowNextHigh
0.00030.029.66
Details
1 Analysts
Consensus
LowTargetHigh
21.8424.0026.64
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Baudax BioInc. Your research has to be compared to or analyzed against Baudax BioInc's peers to derive any actionable benefits. When done correctly, Baudax BioInc's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Baudax BioInc.

Baudax BioInc Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Baudax BioInc is not an exception. The market had few large corrections towards the Baudax BioInc's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Baudax BioInc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Baudax BioInc within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
1.06
β
Beta against NYSE Composite-0.54
σ
Overall volatility
0.01
Ir
Information ratio 0.04

Baudax BioInc Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Baudax BioInc for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Baudax BioInc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Baudax BioInc generated a negative expected return over the last 90 days
Baudax BioInc has high historical volatility and very poor performance
Baudax BioInc has some characteristics of a very speculative penny stock
Baudax BioInc has a very high chance of going through financial distress in the upcoming years
The company currently holds 7.12 M in liabilities with Debt to Equity (D/E) ratio of 2.26, implying the company greatly relies on financing operations through barrowing. Baudax BioInc has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Baudax BioInc until it has trouble settling it off, either with new capital or with free cash flow. So, Baudax BioInc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Baudax BioInc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Baudax to invest in growth at high rates of return. When we think about Baudax BioInc's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 1.27 M. Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (5.74 M).
Baudax BioInc currently holds about 5.65 M in cash with (14.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from MacroaxisInsider: Insider Trading

Baudax BioInc Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Baudax Stock often depends not only on the future outlook of the current and potential Baudax BioInc's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Baudax BioInc's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding331.6 K
Cash And Short Term Investments5.3 M

Baudax BioInc Technical Analysis

Baudax BioInc's future price can be derived by breaking down and analyzing its technical indicators over time. Baudax Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Baudax BioInc. In general, you should focus on analyzing Baudax Stock price patterns and their correlations with different microeconomic environments and drivers.

Baudax BioInc Predictive Forecast Models

Baudax BioInc's time-series forecasting models is one of many Baudax BioInc's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Baudax BioInc's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Baudax BioInc

Checking the ongoing alerts about Baudax BioInc for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Baudax BioInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Baudax BioInc generated a negative expected return over the last 90 days
Baudax BioInc has high historical volatility and very poor performance
Baudax BioInc has some characteristics of a very speculative penny stock
Baudax BioInc has a very high chance of going through financial distress in the upcoming years
The company currently holds 7.12 M in liabilities with Debt to Equity (D/E) ratio of 2.26, implying the company greatly relies on financing operations through barrowing. Baudax BioInc has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Baudax BioInc until it has trouble settling it off, either with new capital or with free cash flow. So, Baudax BioInc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Baudax BioInc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Baudax to invest in growth at high rates of return. When we think about Baudax BioInc's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 1.27 M. Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (5.74 M).
Baudax BioInc currently holds about 5.65 M in cash with (14.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from MacroaxisInsider: Insider Trading
When determining whether Baudax BioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baudax BioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baudax Bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baudax Bioinc Stock:
Check out Baudax BioInc Backtesting, Baudax BioInc Valuation, Baudax BioInc Correlation, Baudax BioInc Hype Analysis, Baudax BioInc Volatility, Baudax BioInc History as well as Baudax BioInc Performance.
For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Baudax Stock analysis

When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(94.13)
Revenue Per Share
0.318
Quarterly Revenue Growth
(0.23)
Return On Assets
(1.15)
Return On Equity
(47.04)
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.